Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
9 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Oramed Pharmaceuticals Inc.’s names, not what it holds today.
Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 1 in 2023
Applications published
23
1 of them in 2025
Names they are printed under
2
a subsidiary
By yearGrantedApplications published
'11'13'14'15'18'19'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Oramed Ltd. a subsidiary
IL, as the owner printed on each patent. 5 more under the same name are not counted (printed in US)
17 publishedORAMED LTD. a subsidiary
named as the applicant on its applications, in IL
6 publishedNames not counted (2)
ORAMED PHARMACEUTICALS INC.
Most of its patents print IL; this name counts in US. 0 granted and 3 published under it are not counted.
ORAMED PHARMACEUTICALS INC.
Most of its patents print IL; this name counts in US. 1 granted and 1 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 30, 2023 | 11,660,327 | Methods and compositions for oral administration of proteins | Pharmaceuticals | Oramed Ltd. |
| Jul 26, 2022 | 11,395,848 | Methods and compositions for treating diabetes | Pharmaceuticals | Oramed Ltd. |
| Apr 6, 2021 | 10,967,051 | Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof | Pharmaceuticals | Oramed Ltd. |
| Mar 2, 2021 | 10,933,022 | Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same | Pharmaceuticals | Oramed Ltd. |
| Jan 5, 2021 | 10,881,714 | Methods and compositions for oral administration of proteins | Pharmaceuticals | Oramed Ltd. |
| Sep 3, 2019 | 10,398,762 | Methods and compositions for treating diabetes | Pharmaceuticals | Oramed Ltd. |
| Jul 16, 2019 | 10,350,162 | Methods and compositions for oral administration of exenatide | Pharmaceuticals | Oramed Ltd. |
| Jul 9, 2019 | 10,342,764 | Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same | Pharmaceuticals | Oramed Ltd. |
| Aug 28, 2018 | 10,058,593 | Methods and compositions for oral administration of proteins | Pharmaceuticals | Oramed Ltd. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 25, 2025 | 2025/0387453 | Methods and Compositions for Treating Diabetes | Pharmaceuticals | ORAMED LTD. |
| Oct 31, 2024 | 2024/0358647 | Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same | Pharmaceuticals | Oramed Ltd. |
| Sep 12, 2024 | 2024/0299503 | Methods and Compositions for Treating Diabetes | Pharmaceuticals | ORAMED LTD. |
| Jun 6, 2024 | 2024/0181018 | Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof | Pharmaceuticals | Oramed Ltd. |
| Jul 6, 2023 | 2023/0210956 | METHODS AND COMPOSITIONS FOR TREATING DIABETES | Pharmaceuticals | Oramed Ltd. |
| Jan 6, 2022 | 2022/0000986 | Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof | Pharmaceuticals | Oramed Ltd. |
| Dec 2, 2021 | 2021/0369626 | Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same | Pharmaceuticals | Oramed Ltd. |
| Oct 21, 2021 | 2021/0322305 | Methods and Compositions for Oral Administration of Exenatide | Pharmaceuticals | ORAMED LTD. |
| Aug 12, 2021 | 2021/0244806 | Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses Thereof | Pharmaceuticals | ORAMED LTD. |
| Apr 22, 2021 | 2021/0113663 | Methods and Compositions for Oral Administration of Proteins | Pharmaceuticals | Oramed Ltd. · patent 11,660,327 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 4.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.